Up First briefing: Trump won't testify; FDA approves landmark gene-editing treatment
Today's top stories
Former President Donald Trump announced yesterday he won't testify for a second time as planned in the New York civil fraud trial against him and his company. His lawyers previously said he would be at the witness stand today. But Trump posted on his social media platform, Truth Social, that he "already testified to everything" and had "nothing more to say."
The Doha Forum, an annual policy meeting, resumes in Qatar today. This year's gathering has largely focused on the war in Gaza and its impact on regional security. Qatar, a U.S. ally, played an active role in negotiating the temporary cease-fire to allow for the release of hostages taken by Hamas on Oct. 7 in exchange for Palestinian prisoners.
Check out npr.org/mideastupdates for more coverage and analysis of this conflict.
University of Pennsylvania president Liz Magill resigned this weekend after receiving criticism for her congressional testimony on campus antisemitism. Scott Bok, the chair of the university's board of trustees, also stepped down. Magill joined the presidents of Harvard and MIT last week to answer questions about how their schools were protecting students from antisemitism. Their answers to whether "calling for the genocide of the Jews" would violate university codes of conduct drew fierce backlash.
The FDA has approved the first gene-edited treatment for a human illness. The landmark decision approved two gene therapies for people 12 and over suffering from the most severe sickle cell disease, a blood disorder that affects about 100,000 Americans. Jennifer Doudna, who helped discover the CRISPR gene editing technology used in one of the treatments, said she was "elated, excited, in awe," but said there's more work to do. The treatments are very expensive and require complicated procedures many hospitals may not be equipped to provide.
It's the holiday season, and the temptation to buy brand-new gifts for everyone on your list is strong. But mindless consumption is a major burden on our resources. Here's how you can be kinder to the environment — and your wallet — when shopping for holiday gifts:
No one is more upset about Chuck E. Cheese getting rid of its animatronics than the adults. A spokesperson for the company said kids today have "higher expectations of realism and special effects," so they won't miss them. Even so, some parents are taking their kids to their local Chuck E. Cheese for the last chance to show them a piece of their childhood. Photographer Maggie Shannon documented the last generation of kids making memories with Chuck E. Cheese's animatronics.
3 things to know before you go
Copyright 2023 NPR. To see more, visit https://www.npr.org.